Legal & General Group PLC Merrimack Pharmaceuticals Inc Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$13.06 - $15.0 $3,996 - $4,590
-306 Reduced 23.79%
980 $14,000
Q2 2023

Aug 14, 2023
BUY
$12.02 - $13.07 $15,457 - $16,808
1,286 New
1,286 $15,000
Q2 2018

Aug 10, 2018
SELL
$3.86 - $7.61 $10,422 - $20,547
-2,700 Closed
0 $0
Q1 2018

May 17, 2018
SELL
$6.24 - $9.15 $6,452 - $9,461
-1,034 Reduced 27.69%
2,700 $22,000
Q4 2017

Feb 13, 2018
BUY
$7.99 - $11.87 $29,834 - $44,322
3,734
3,734 $39,000

Others Institutions Holding MACK

# of Institutions
2
Shares Held
349
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email